Credit Suisse Ag Pulmonx Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Pulmonx Corp stock. As of the latest transaction made, Credit Suisse Ag holds 48,127 shares of LUNG stock, worth $305,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,127

Previous 45,796 5.09%

Holding current value

$305,125

Previous $583,000 23.5%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.71 - $14.65 $20,303 - $34,149	2,331 Added 5.09%	48,127 $446,000
Q4 2023 Feb 08, 2024	BUY	$7.89 - $13.14 $11,219 - $18,685	1,422 Added 3.2%	45,796 $583,000
Q3 2023 Nov 13, 2023	BUY	$9.88 - $14.0 $88,722 - $125,720	8,980 Added 25.37%	44,374 $458,000
Q2 2023 Aug 11, 2023	BUY	$10.78 - $13.65 $42,214 - $53,453	3,916 Added 12.44%	35,394 $464,000
Q1 2023 May 10, 2023	BUY	$7.49 - $12.54 $28,941 - $48,454	3,864 Added 13.99%	31,478 $351,000

Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $30,646 - $108,073	6,229 Added 29.13%	27,614 $232,000
Q3 2022 Nov 10, 2022	BUY	$15.35 - $23.99 $65,437 - $102,269	4,263 Added 24.9%	21,385 $356,000
Q2 2022 Aug 12, 2022	BUY	$14.0 - $27.95 $20,230 - $40,387	1,445 Added 9.22%	17,122 $252,000
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $58,551 - $98,786	2,771 Added 21.47%	15,677 $390,000
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $15,692 - $23,812	528 Added 4.27%	12,906 $413,000
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $51,199 - $63,295	1,423 Added 12.99%	12,378 $446,000
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $412,017 - $525,840	10,955 New	10,955 $484,000
Q1 2021 May 14, 2021	SELL	$44.0 - $67.54 $145,860 - $223,895	-3,315 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $130,312 - $228,801	3,315 New	3,315 $229,000

Others Institutions Holding LUNG

# of Institutions

124

Shares Held

30.8M

Call Options Held

1.2K

Put Options Held

1.2K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account